1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. COHANCE LIFESCIENCES LTD.
Cohance Lifesciences Ltd. Ask MarketMind AI v1.5
NSE: COHANCE | BSE: 543064

Cohance Lifesciences Live Share Price Today, Share Analysis and Chart

Expensive Performer
Iran war impact

Based on the recent financial disclosures and investor communications of Cohance Lifesciences Ltd., the impact of the Middle East conflict is categorized as Minimal to Indirectly Negative. The company does not have a high direct revenue depen...

Read More
360.10 -3.80 (-1.04%)
70.47% Fall from 52W High
961.4K
NSE+BSE Volume

NSE 24 Apr, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
Medium Financial Strength
- / 100
Valuation Score
Expensive Valuation
- / 100
Momentum Score
Technically Neutral
38.7 / 100
Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM
Analyst Price Target
478
1Yr Price target upside is 33%
9 analysts

9

S

14

W

5

O

1

T

SWOT Analysis

Cohance Lifesciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
VOTE: Is Suven Pharmaceuticals Ltd. worth buying?
53 Votes:
Buy 69.81%
Sell 16.98%
Hold 13.21%
BUY
SELL
HOLD
Ask AI